# Safety And Efficacy Of Rifabutin In Patients For Non-HIV Patients

> **NCT00810407** · — · COMPLETED · sponsor: **Pfizer** · enrollment: 628 (actual)

## Conditions studied

- Tuberculosis
- Non-tuberculous Mycobacterial Diseases (Including MAC Disease)

## Interventions

- **DRUG:** rifabutin

## Key facts

- **NCT ID:** NCT00810407
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-11
- **Primary completion:** 2016-07
- **Final completion:** 2016-07
- **Target enrollment:** 628 (ACTUAL)
- **Last updated:** 2019-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00810407

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00810407, "Safety And Efficacy Of Rifabutin In Patients For Non-HIV Patients". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00810407. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*